Clinical trial in cardiology received final approval

25 July 2007

Final approval of the Ministry of Health of Russian Federation for clinical trial in acute myocardial infarction was obtained in 2 months after initial submission. The final approval of this study in Ukraine was obtained in less than 2 months after submission.

OCT Vision

“OCT vision is to be recognized by pharmaceutical and biotech companies as a leading provider of clinical trials in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia, Poland and Czech Republic. OCT is able to support any requirements that clients may have in the region, ranging from one-off advice to full-study implementation and execution. We are determined and decisive in expanding our activity at this rapidly growing market”— Dmitry Sharov, General Manager of OCT.